Reports- Guaifenesin (API) Market | Page 3

1.4 Market Analysis by States 1.4.1 California Status and Prospect (2012-2022) 1.4.2 Texas Status and Prospect (2012-2022) 1.4.3 New York Status and Prospect (2012-2022) 1.4.4 Florida Status and Prospect (2012-2022) 1.4.5 Illinois Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Granules 2.1.1 Profile 2.1.2 Guaifenesin (API) Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Granules Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 Granules News 2.2 Synthokem Labs 2.2.1 Profile 2.2.2 Guaifenesin (API) Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Synthokem Labs Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.4 Business Overview 2.2.5 Synthokem Labs News 2.3 Haizhou Pharma 2.3.1 Profile 2.3.2 Guaifenesin (API) Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Haizhou Pharma Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.4 Business Overview 2.3.5 Haizhou Pharma News 2.4 Yuan Cheng Group 2.4.1 Profile 2.4.2 Guaifenesin (API) Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.4 Business Overview 2.4.5 Yuan Cheng Group News 2.5 Stellar Chemical 2.5.1 Profile 2.5.2 Guaifenesin (API) Type and Applications